Literature DB >> 11369864

Interaction energies between beta-lactam antibiotics and E. coli penicillin-binding protein 5 by reversible thermal denaturation.

B M Beadle1, R A Nicholas, B K Shoichet.   

Abstract

Penicillin-binding proteins (PBPs) catalyze the final stages of bacterial cell wall biosynthesis. PBPs form stable covalent complexes with beta-lactam antibiotics, leading to PBP inactivation and ultimately cell death. To understand more clearly how PBPs recognize beta-lactam antibiotics, it is important to know their energies of interaction. Because beta-lactam antibiotics bind covalently to PBPs, these energies are difficult to measure through binding equilibria. However, the noncovalent interaction energies between beta-lactam antibiotics and a PBP can be determined through reversible denaturation of enzyme-antibiotic complexes. Escherichia coli PBP 5, a D-alanine carboxypeptidase, was reversibly denatured by temperature in an apparently two-state manner with a temperature of melting (T(m)) of 48.5 degrees C and a van't Hoff enthalpy of unfolding (H(VH)) of 193 kcal/mole. The binding of the beta-lactam antibiotics cefoxitin, cloxacillin, moxalactam, and imipenem all stabilized the enzyme significantly, with T(m) values as high as +4.6 degrees C (a noncovalent interaction energy of +2.7 kcal/mole). Interestingly, the noncovalent interaction energies of these ligands did not correlate with their second-order acylation rate constants (k(2)/K'). These rate constants indicate the potency of a covalent inhibitor, but they appear to have little to do with interactions within covalent complexes, which is the state of the enzyme often used for structure-based inhibitor design.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369864      PMCID: PMC2374021          DOI: 10.1110/ps.52001

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  17 in total

1.  On the origin of bacterial resistance to penicillin: comparison of a beta-lactamase and a penicillin target.

Authors:  J A Kelly; O Dideberg; P Charlier; J P Wery; M Libert; P C Moews; J R Knox; C Duez; C Fraipont; B Joris
Journal:  Science       Date:  1986-03-21       Impact factor: 47.728

2.  Protein stability curves.

Authors:  W J Becktel; J A Schellman
Journal:  Biopolymers       Date:  1987-11       Impact factor: 2.505

3.  Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine.

Authors:  D J Tipper; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1965-10       Impact factor: 11.205

4.  Characterization of covalently bound enzyme inhibitors as transition-state analogs by protein stability measurements: phosphonate monoester inhibitors of a beta-lactamase.

Authors:  J Rahil; R F Pratt
Journal:  Biochemistry       Date:  1994-01-11       Impact factor: 3.162

5.  Interaction between the exocellular DD-carboxypeptidase-transpeptidase from Streptomyces R61, substrate and beta-lactam antibiotics. A choice of models.

Authors:  J M Frère; J M Ghuysen; H R Perkins
Journal:  Eur J Biochem       Date:  1975-09-15

6.  Functional analyses of AmpC beta-lactamase through differential stability.

Authors:  B M Beadle; S L McGovern; A Patera; B K Shoichet
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

7.  Crystallographic mapping of beta-lactams bound to a D-alanyl-D-alanine peptidase target enzyme.

Authors:  J A Kelly; J R Knox; H Zhao; J M Frère; J M Ghaysen
Journal:  J Mol Biol       Date:  1989-09-20       Impact factor: 5.469

8.  Crystal structure of a deacylation-defective mutant of penicillin-binding protein 5 at 2.3-A resolution.

Authors:  C Davies; S W White; R A Nicholas
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

9.  Site-directed mutants of a soluble form of penicillin-binding protein 5 from Escherichia coli and their catalytic properties.

Authors:  R A Nicholas; J L Strominger
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

10.  Penicillin-binding protein 2x of Streptococcus pneumoniae: enzymic activities and interactions with beta-lactams.

Authors:  M Jamin; C Damblon; S Millier; R Hakenbeck; J M Frère
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

View more
  7 in total

1.  Crystal structures of covalent complexes of β-lactam antibiotics with Escherichia coli penicillin-binding protein 5: toward an understanding of antibiotic specificity.

Authors:  George Nicola; Joshua Tomberg; R F Pratt; Robert A Nicholas; Christopher Davies
Journal:  Biochemistry       Date:  2010-09-21       Impact factor: 3.162

2.  The role of the β5-α11 loop in the active-site dynamics of acylated penicillin-binding protein A from Mycobacterium tuberculosis.

Authors:  Alena Fedarovich; Robert A Nicholas; Christopher Davies
Journal:  J Mol Biol       Date:  2012-02-23       Impact factor: 5.469

3.  Influence of the α-Methoxy Group on the Reaction of Temocillin with Pseudomonas aeruginosa PBP3 and CTX-M-14 β-Lactamase.

Authors:  Michael D Sacco; Kyle G Kroeck; M Trent Kemp; Xiujun Zhang; Logan D Andrews; Yu Chen
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

4.  Protein Stability Effects in Aggregate-Based Enzyme Inhibition.

Authors:  Hayarpi Torosyan; Brian K Shoichet
Journal:  J Med Chem       Date:  2019-10-17       Impact factor: 7.446

5.  The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.

Authors:  Ryan P Lamers; Joseph F Cavallari; Lori L Burrows
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

6.  Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking.

Authors:  Dariusz Ekonomiuk; Xun-Cheng Su; Kiyoshi Ozawa; Christophe Bodenreider; Siew Pheng Lim; Zheng Yin; Thomas H Keller; David Beer; Viral Patel; Gottfried Otting; Amedeo Caflisch; Danzhi Huang
Journal:  PLoS Negl Trop Dis       Date:  2009-01-13

Review 7.  β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects.

Authors:  Karl A Glen; Iain L Lamont
Journal:  Pathogens       Date:  2021-12-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.